Pyrrolochinolin-Chinon (PQQ) und mitochondriale Biogenese in RGZ
PQQ wurde erstmals entdeckt als Kofaktor fÌr bestimmte bakterielle Enzyme, spÀter jedoch als wichtig fÌr die TierernÀhrung befunden. Da Tiere PQQ...
èŠèŠå¥åº·ãç¶æããããã®è©³çްãªç ç©¶ãšå°éå®¶ã¬ã€ãã
PQQ wurde erstmals entdeckt als Kofaktor fÌr bestimmte bakterielle Enzyme, spÀter jedoch als wichtig fÌr die TierernÀhrung befunden. Da Tiere PQQ...
PQQ upptÀcktes först som en kofaktor för vissa bakterieenzymer, men visade sig senare vara viktig i djurnÀring. Eftersom djur inte kan producera PQQ...
IGF-1 Àr ett litet proteinhormon nÀra beslÀktat med insulin. Det bildas i levern (och i vissa vÀvnader) under påverkan av tillvÀxthormon. I kroppen...
IGF-1 ist ein kleines Proteinhormon, das eng mit Insulin verwandt ist. Es wird in der Leber (und in einigen Geweben) unter dem Einfluss von...
IGF-1 is a small protein hormone closely related to insulin. It is made in the liver (and in some tissues) under the influence of growth hormone. In...
5å以å ã«ç¡æã®èŠéæ€æ»ãéå§ã§ããŸãã
ä»ãããã¹ããéå§Neurodegeneration describes the progressive loss of structure or function of nerve cells, including their death, which affects how the brain and nervous system work over time. Conditions that involve this process usually get worse gradually and can affect memory, movement, thinking, or senses depending on which cells and brain regions are damaged. Common examples include diseases that cause memory loss, tremors, or trouble walking, but the term covers any situation where nerve cells decline and fail to communicate properly. Early signs can be subtleâlike small memory lapses, slowed movements, or mood changesâbut symptoms typically grow more serious as more cells are affected. Because nerve cells are difficult to replace, damage is often long-lasting and can lead to disability. Researchers believe many factors contribute to neurodegeneration, including abnormal protein build-up inside or around cells, inflammation, problems with energy production in cells, and genetic vulnerabilities. Age is the biggest risk factor, but infections, toxins, head injuries, and metabolic problems can also play roles. Current treatments mostly aim to manage symptoms or slow decline rather than cure the underlying process, so prevention and early detection are major areas of interest. Scientists are exploring ways to protect nerve cells, clear harmful proteins, and boost repair, with the hope of developing better therapies. Understanding neurodegeneration matters because populations are aging worldwide, increasing the number of people affected and the social and medical impact on families and health systems.